-
1
Characterization of Selective and Potent JAK1 Inhibitors Intended for the Inhaled Treatment of Asthma
Published 2022-08-01Subjects: “…azd0449…”
Get full text
Article -
2
-
3
The Application of ATR Kinase Inhibitor AZD6738 in Combination with Radiotherapy for the Treatment of Melanoma
Published 2022-06-01Subjects: “…azd6738…”
Get full text
Article -
4
A Critical Analysis of the Use of Cilgavimab plus Tixagevimab Monoclonal Antibody Cocktail (Evusheld™) for COVID-19 Prophylaxis and Treatment
Published 2022-09-01Subjects: Get full text
Article -
5
TOPBP1 as a potential predictive biomarker for enhanced combinatorial efficacy of olaparib and AZD6738 in PDAC
Published 2025-02-01Subjects: Get full text
Article -
6
AZD0530 sensitizes drug‐resistant ALK‐positive lung cancer cells by inhibiting SRC signaling
Published 2017-04-01Subjects: Get full text
Article -
7
Cytotoxic Effects Of Selective Inhibitor ‘Aurora Kinase B’ On Viability And Metabolic Features Of Human Promyelocytic Leukemia Cell Line
Published 2013-09-01Subjects: Get full text
Article -
8
Anti-tumor effect of AZD8055 against bladder cancer and bladder cancer-associated macrophages
Published 2023-03-01Subjects: “…AZD8055…”
Get full text
Article -
9
A case report of toxic epidermal necrolysis associated with AZD-9291
Published 2018-07-01Subjects: Get full text
Article -
10
Comprehensive analysis of circular RNA profiling in AZD9291‐resistant non‐small cell lung cancer cell lines
Published 2019-04-01Subjects: “…AZD9291…”
Get full text
Article -
11
-
12
Checkpoint kinase inhibitor AZD7762 enhance cisplatin-induced apoptosis in osteosarcoma cells
Published 2019-07-01Subjects: “…AZD7762…”
Get full text
Article -
13
Effectiveness of AZD7442 (Tixagevimab/Cilgavimab) for Pre-Exposure Prophylaxis Against COVID-19 Hospitalization in Israel During the Omicron Sub-Variant Time Period
Published 2025-01-01Subjects: “…AZD7442…”
Get full text
Article -
14
Aurora kinase B inhibitor AZD1152: repurposing for treatment of lupus nephritis driven by the results of clinical trialsResearch in context
Published 2025-02-01Subjects: Get full text
Article -
15
-
16
Deciphering metabolic heterogeneity in retinoblastoma unravels the role of monocarboxylate transporter 1 in tumor progression
Published 2024-05-01Subjects: Get full text
Article -
17
Targeting ERK1/2 activation and proliferation in human primary schwannoma cells with MEK1/2 inhibitor AZD6244
Published 2010-01-01Subjects: Get full text
Article -
18
AZD2014, a dual mTOR inhibitor, attenuates cardiac hypertrophy in vitro and in vivo
Published 2021-10-01Subjects: “…AZD2014…”
Get full text
Article -
19
AZD5153 Inhibits Prostate Cancer Cell Growth in Vitro and in Vivo
Published 2018-10-01Subjects: Get full text
Article -
20
Improvement in insulin sensitivity and prevention of high fat diet-induced liver pathology using a CXCR2 antagonist
Published 2022-07-01Subjects: Get full text
Article